Navigation Links
A New Diagnostic Approach To Pediatric Interstitial Lung Disease

Chronic interstitial lung disease (ILD) comprises a large, heterogeneous group of rare pulmonary disorders //characterized by diffuse infiltrates, restrictive lung disease, and abnormal gas exchange with considerable mortality and morbidity. ILD presents enormous diagnostic challenges because the differential diagnosis includes more than 100 conditions in both adults2 and children.

Researchers from Texas and Colorado conducted a descriptive, observational study was to evaluate the value of a systematic approach to the diagnosis of pediatric ILD. The study appears in the journal Pediatrics (vol. 101). In this prospective study, the researchers evaluated 51 children presenting with ILD of unknown etiology during a 3-year period. Specific clinical information regarding history, physical examination, diagnostic evaluation, and final diagnosis was recorded on each patient.

A specific diagnosis was established by history and physical examination alone in 1 patient, noninvasive tests alone in 8 others, and invasive tests, including lung biopsy, in another 26. Of the remaining patients, 8 had a suggestive diagnosis, and 8 had no specific diagnosis.

In this study, all of the patients who did not have ITs are currently living, whereas all of the deaths or tranplant occurred in patients who had had ITs. Although the series was small, this observation suggests that the algorithm was utilized appropriately, reserving the most invasive studies for the sickest patients.

In conclusion, this study demonstrates that pediatric ILD comprises a heterogeneous group of mostly rare disorders that present tremendous diagnostic challenges. A systematic approach to the diagnosis of pediatric ILD is useful, and not all patients need lung biopsy for diagnosis.

The authors stress that a systematic evaluation will preclude the need for invasive tests in some patients. Although this series is one of the largest to be reported in ch ildren, the study suffers from small numbers relative to those reported for adult ILD. Because no single pediatric center can see large numbers of pediatric ILD patients, multi center collaboration will be required to extend these observations.

Medindia on Lung cancer:

Lung cancer is the uncontrolled growth of abnormal cells in the lung. Majority of people who get lung cancer have been cigarette smokers, but not all people who smoke get lung cancer. And, some people who have never smoked get lung cancer. Normal lung tissue is made up of cells that are programmed by nature to create lungs of a certain shape and function.

Related medicine news :

1. Cancer Risk From Exposure To Diagnostic X-Rays
2. Fragile X-Associated Tremor /Ataxia Syndrome Need Guidelines For Diagnostic Tests
3. Schizophrenia Gets A New Diagnostic Tool
4. Diagnostic Procedure For Tuberculosis Made Easy
5. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
6. Diagnostic Test Launched by Ranbaxy for En Masse Screening of Bird Flu
7. Diagnostic Centre Inaugurated for Air Pollution at SRMC
8. Lab Tests And Diagnostics - Next Wave Of Outsourcing
9. New Diagnostic Tool Uncovered Gene Expression Patterns in Recessive Genetic Disorders
10. eGFR Diagnostic Test -A reliable and understandable measure of kidney impairment
11. Obesity Hinders Medical Diagnostic Tests
Post Your Comments:

(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Clinical Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The ... published in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... client, The Grove Investment Group (TGIG), has initiated cultivation and processing operations at ... Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm Slone Partners ... extensive sequencing and genomics experience, as Vice President of North American Capital Sales at ... responsible for leading the sales team in the commercialization of the HTG EdgeSeq system ...
(Date:6/24/2016)... ... 24, 2016 , ... Today, MTI-GlobalStem, a provider of optimized ... difficult to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing ... is a complete system for culturing and transfecting human pluripotent stem cells ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... , June 23, 2016 Bracket , a ... its next generation clinical outcomes platform, Bracket eCOA (SM) ... on June 26 – 30, 2016 in Philadelphia ... electronic Clinical Outcome Assessment product of its kind to fully ... Bracket eCOA 6.0 is a flexible platform for ...
(Date:6/23/2016)... 23, 2016  Guerbet announced today that it has ... Horizon Award . One of 12 suppliers ... for its support of Premier members through exceptional local ... and commitment to lower costs. ... of our outstanding customer service from Premier," says ...
Breaking Medicine Technology: